Melanoma Journal Articles for February 2018
Science Translational Medicine
Eradication of spontaneous malignancy by local immunotherapy
Idit Sagiv-Barfi1, Debra K. Czerwinski1, Shoshana Levy1, Israt S. Alam2, Aaron T. Mayer2, Sanjiv S. Gambhir2 and Ronald Levy1,*
Science Translational Medicine 31 Jan 2018:
Vol. 10, Issue 426, eaan4488
DOI: 10.1126/scitranslmed.aan4488
Journal of Clinical Oncology
Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator’s Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial
James Larkin, David Minor, Sandra D’Angelo, Bart Neyns, Michael Smylie, Wilson H. Miller Jr, et al.
DOI: 10.1200/JCO.2016.71.8023
Journal of Clinical Oncology 36, no. 4 (February 2018) 383-390.
The FEBS Journal
Exosomes derived from B16F0 melanoma cells alter the transcriptome of cytotoxic T cells that impacts mitochondrial respiration
Cassidy L. Bland, Christina N. Byrne-Hoffman, Audry Fernandez, Stephanie L. Rellick, Wentao Deng, David J. Klinke
Accepted manuscript online: 5 February 2018
DOI: 10.1111/febs.1439
Molecular Pharmaceutics
Solid-in-Oil Peptide Nanocarriers for Transcutaneous Cancer Vaccine Delivery against Melanoma
Rie Wakabayashi, Masato Sakuragi, Shuto Kozaka, Yoshiro Tahara, Noriho Kamiya, and Masahiro Goto
Mol. Pharmaceutics, Just Accepted Manuscript
DOI: 10.1021/acs.molpharmaceut.7b00894
Publication Date (Web): February 5, 2018
American Association for Clinical Chemistry – Letters to the Editor
Optimizing Amplification of the GC-Rich TERT Promoter Region Using 7-Deaza-dGTP for Droplet Digital PCR Quantification of TERT Promoter Mutations
Andrew J. Colebatch, Tom Witkowski, Paul M. Waring, Grant A. McArthur, Stephen Q. Wong, Alexander Dobrovic
Papers in Press. Published January 30, 2018 as doi:10.1373/clinchem.2017.284257
Clinical Chemistry 64:4 000–000 (2018)
Systemic treatments for metastatic cutaneous melanoma
Sandro Pasquali, Andreas V Hadjinicolaou, Vanna Chiarion Sileni, Carlo Riccardo Rossi, Simone Mocellin
First published: 6 February 2018
Editorial Group: Cochrane Skin Group
DOI: 10.1002/14651858.CD011123.pub2
British Journal of Dermatology
Wide skin markings pattern – melanoma descriptor or patient-related factor?
A. Rishpon, M. Marchetti, A. Marghoob
Accepted manuscript online: 6 February 2018
DOI: 10.1111/bjd.16420
RSC Advances
SNHG5 promotes proliferation and induces apoptosis in melanoma by sponging miR-155
Lu Yan,*a Suihai Wang,b Yue Li,c Linda Tognetti,d Rui Tan,a Kang Zeng,e Elisa Pianigiani,d Xiangbin Mi,a Hui Li,a Michele Fimianid and Pietro Rubegni*d
received on 17 Nov 2017, accepted on 26 Jan 2018 and first published on 07 Feb 2018
DOI: 10.1039/C7RA12520H
Ocular Oncology and Pathology
Original Paper
The Patient’s Experience of Ocular Melanoma in the US: A Survey of the Ocular Melanoma Foundation
Afshar A.R.a · Deiner M.a · Allen G.b · Damato B.E.a, c
Ocul Oncol Pathol 2018;4:280-290
https://doi.org/10.1159/000485189Ocul Oncol Pathol 2018;4:280-290
JAMA Oncology
Association Between Circulating Tumor DNA and Pseudoprogression in Patients With Metastatic Melanoma Treated With Anti–Programmed Cell Death 1 Antibodies
Jenny H. Lee, MBBS1,2,3; Georgina V. Long, PhD2,4,5; Alexander M. Menzies, PhD2,4,5; et al
JAMA Oncol. Published online February 8, 2018. doi:10.1001/jamaoncol.2017.5332
Journal of Medicinal Chemistry
Glutathione S-Transferase ?-Activatable O2-(Sulfonylethyl Derived) Diazeniumdiolates Potently Suppress Melanoma In Vitro and In Vivo
Zhangjian Huang, Jianbing Wu, Yu Zou, Haoliang Yuan, Yinqiu Zhang, Yue Fei, Atul Bhardwaj, Jatinder Kaur, Edward E. Knaus, and Yihua Zhang
- Med. Chem., Just Accepted Manuscript
DOI: 10.1021/acs.jmedchem.7b01178
Publication Date (Web): February 8, 2018
Oncology Letters
Macrophages in skin melanoma-the key element in melanomagenesis (Review)
Malgorzata Pieniazek, Rafal Matkowski, Piotr Donizy
Published online on: February 9, 2018 https://doi.org/10.3892/ol.2018.8021
Sensors 2018, 18(2), 556; doi:10.3390/s18020556
Skin Lesion Analysis towards Melanoma Detection Using Deep Learning Network
Yuexiang Li andLinlin Shen
Received: 19 December 2017 / Revised: 8 February 2018 / Accepted: 8 February 2018 / Published: 11 February 2018
Asian Oncology Research Journal, 1(1): 1-8, 2018; Article no.AORJ.39053
Case Study
Primary Mucosal Melanoma of Upper Alveolar Ridge and Hard Palate – A Case Report
F. Massilamani1, S. Kailasam1, C. K. Vishnu Priya1*and R. Poorani2
DOI: 10.9734/AORJ/2018/39053
Received 28th November 2017 Accepted 5th February 2018 Published 12th February 2018
Journal of Clinical Oncology
Nivolumab Plus Ipilimumab in Patients With Advanced Melanoma: Updated Survival, Response, and Safety Data in a Phase I Dose-Escalation Study
Margaret K. Callahan, Harriet Kluger, Michael A. Postow, Neil H. Segal, Alexander Lesokhin, Michael B. Atkins,
DOI: 10.1200/JCO.2017.72.2850 Journal of Clinical Oncology 36, no. 4 (February 2018) 391-398.
Histopathology
High density of M2-macrophages in acral lentiginous melanoma compared to superficial spreading melanoma
M Zúñiga-Castillo, NV Pereira, MN Sotto
Accepted manuscript online: 7 February 2018
DOI: 10.1111/his.13478
Cancer Research
Research Article
RSK Regulates PFK-2 Activity to Promote Metabolic Rewiring in Melanoma
Thibault Houles, SimonPierre Gravel, Geneviève Lavoie, Sejeong Shin, Mathilde Savall, Antoine Méant, Benoit Grondin, Louis Gaboury, Sang-Oh Yoon, Julie St-Pierre and Philippe P Roux
DOI: 10.1158/0008-5472.CAN-17-2215
J Am Acad Dermatol. 2018 Feb 10. pii: S0190-9622(18)30205-6. doi: 10.1016/j.jaad.2018.02.019. [Epub ahead of print]
Whole-exome sequencing reveals differences between nail apparatus melanoma and acral melanoma.
Lee M1, Yoon J1, Chung YJ1, Lee SY2, Choi JY2, Shin OR3, Park HY4, Bahk WJ4, Yu DS2, Lee YB5.
PMID: 29438763
DOI: 10.1016/j.jaad.2018.02.019
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis
Jennifer L McQuade, Carrie R Daniel, PhD, Prof Kenneth R Hess, PhD, Carmen Mak, PhD, Daniel Y Wang, MD, Rajat R Rai, MD, John J Park, MD, Lauren E Haydu, PhD, Christine Spencer, MPH, Matthew Wongchenko, BS, Stephen Lane, MS, Dung-Yang Lee, PhD, Mathilde Kaper, MA, Meredith McKean, MD, Kathryn E Beckermann, MD, Samuel M Rubinstein, MD, Isabelle Rooney, MD, Luna Musib, PhD, Nageshwar Budha, PhD, Jessie Hsu, PhD, Theodore S Nowicki,
DOI: https://doi.org/10.1016/S1470-2045(18)30078-0
Published: 12 February 2018
NEJM
Correspondence
Adjuvant Therapy in Resected Melanoma
Ana Rita J. Maria, M.D., Catarina Viegas Dias, M.D., Bruno Heleno, M.D., Ph.D., NOVA Medical School, Lisbon, Portugal
February 15, 2018
N Engl J Med 2018; 378:678-680
DOI: 10.1056/NEJMc1716071
PNAS
Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapy
Xin Hong, Ryan J. Sullivan, Mark Kalinich, Tanya Todorova Kwan, Anita Giobbie-Hurder, Shiwei Pan, Joseph A. LiCausi, John D. Milner, Linda T. Nieman, Ben S. Wittner, Uyen Ho, Tianqi Chen, Ravi Kapur, Donald P. Lawrence, Keith T. Flaherty, Lecia V. Sequist, Sridhar Ramaswamy, David T. Miyamoto, Michael Lawrence, Mehmet Toner, Kurt J. Isselbacher, Shyamala Maheswaran and Daniel A. Haber
PNAS 2018; published ahead of print February 16, 2018, https://doi.org/10.1073/pnas.1719264115
British Journal of Dermatology
Beyond country-specific incidence and mortality: the global burden of melanoma
Authors
K.J.L. Bell, A.E. Cust
First published: 14 February 2018
DOI: 10.1111/bjd.15688
Oncology
Case Report
Severe Adverse Reaction to Vemurafenib in a Pregnant Woman with Metastatic Melanoma
de Haan J.a,b · van Thienen J.V.c · Casaer M.d · Hannivoort R.A.e · Van Calsteren K.f · van Tuyl M.g ·van Gerwen M.M.h · Debeer A.i · Amant F.b,h,j · Painter R.C.k
Case Rep Oncol 2018;11:119–124
https://doi.org/10.1159/000487128
Journal of Neuro-oncology
The impact of timing of immunotherapy with cranial irradiation in melanoma patients with brain metastases: intracranial progression, survival and toxicity
Rifaquat Rahman, Alfonso Cortes, Andrzej Niemierko, Kevin S. Oh, Keith T. Flaherty, Donald P. Lawrence, Ryan J. Sullivan, Helen A. Shih
DOIhttps://doi.org/10.1007/s11060-018-2795-7
British Journal of Dermatology
Prognostic features for acral lentiginous melanoma
A.E. Cust
First published: 14 February 2018
DOI: 10.1111/bjd.16163
Virchows Archiv A
Survival with primary cutaneous malignant melanoma, evaluated from 2012 cases
A multivariate regression analysis
Søndergaard, K. & Schou, G. Vichows Archiv A Pathol Anat (1985) 406: 179. https://doi.org/10.1007/BF00737084
June 1985, Volume 406, Issue 2, pp 179–195
DOIhttps://doi.org/10.1007/BF00737084
JAMA Dermatology
Brief Report
February 16, 2018
Examining the Incidence and Presentation of Melanoma in the Cardiothoracic Transplant Population
Charles J. Puza, BA1; Adela R. Cardones, MD2; Paul J. Mosca, MD, PhD, MBA3
JAMA Dermatol. Published online February 16, 2018. doi:10.1001/jamadermatol.2018.0130
Clin Exp Dermatol. 2018 Feb 16. doi: 10.1111/ced.13393. [Epub ahead of print]
Association of clinicopathological features of melanoma with total naevus count and a history of dysplastic naevi: a cross-sectional retrospective study within an academic centre.
Tan SY1, Strazzulla LC2, Li X3,4, Park JJ5, Lee SJ1,3, Kim CC6.
PMID: 29450912
DOI: 10.1111/ced.13393
BMC
Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype
Tobias Sinnberg, Mitchell P. Levesque, Jelena Krochmann, Phil F. Cheng, Kristian Ikenberg, Francisco Meraz-Torres, Heike Niessner, Claus Garbe and Christian Busch
Molecular Cancer201817:59
https://doi.org/10.1186/s12943-018-0773-5
Received: 2 October 2017
Accepted: 29 January 2018
Published: 17 February 2018
Pigment cell & melanoma research
A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma
Janice M. Mehnert, Ann W. Silk, Yu Wen, J. H. Lee, Liesel Dudek, Byeong-Seon Jeong, Jiadong Li, Jason M. Schenkel, Evita Sadimin, Michael Kane, Hongxia Lin, Weichung J. Shih, Andrew Zloza, Suzie Chen, James. S. Goydos
Accepted manuscript online: 17 February 2018
DOI: 10.1111/pcmr.12694
Int. J. Mol. Sci. 2018, 19(2), 607; doi:10.3390/ijms19020607 (registering DOI)
Nanomechanical Phenotype of Melanoma Cells Depends Solely on the Amount of Endogenous Pigment in the Cells
Michal Sarna, Andrzej Zadlo, Barbara Czuba-Pelech and Krystyna Urbanska
Received: 19 December 2017; Accepted: 7 February 2018; Published: 18 February 2018
Journal of Extracellular Vesicles
Volume 7, 2018 – Issue 1
Immunoaffinity-based isolation of melanoma cell-derived exosomes from plasma of patients with melanoma
Priyanka Sharma,Sonja Ludwig,Laurent Muller,Chang Sook Hong,John M Kirkwood,Soldano Ferrone & show all
Article: 1435138 | Received 12 Sep 2017, Accepted 26 Jan 2018, Published online: 15 Feb 2018
https://doi.org/10.1080/20013078.2018.143513
Science Signaling
Abl and Arg mediate cysteine cathepsin secretion to facilitate melanoma invasion and metastasis
Rakshamani Tripathi1, Leann S. Fiore1, Dana L. Richards2, Yuchen Yang3, Jinpeng Liu4, Chi Wang4, and Rina Plattner1,*
Sci. Signal. 20 Feb 2018:
Vol. 11, Issue 518, eaao0422
DOI: 10.1126/scisignal.aao0422
Dove Press
Role of ubenimex as an anticancer drug and its synergistic effect with Akt inhibitor in human A375 and A2058 cells
Authors Wang X, Liu Y, Wu R, Guo F, Zhang L, Cui M, Wu X, Zhang Y, Liu W
Received 19 November 2017
Accepted for publication 12 January 2018
Published 22 February 2018 Volume 2018:11 Pages 943—953
DOI https://doi.org/10.2147/OTT.S157480
Dove Press
Characterization of luteinizing hormone-releasing hormone receptor type I (LH-RH-I) as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines
Authors Sipos E, Dobos N, Rozsa D, Fodor K, Olah G, Szabo Z, Szekvolgyi L, Schally AV, Halmos G
Received 3 August 2017
Accepted for publication 25 November 2017
Published 22 February 2018 Volume 2018:11 Pages 933—941
DOI https://doi.org/10.2147/OTT.S148174
Epidemiology of Melanoma.
Authors
Matthews NH2, Li WQ2,3, Qureshi AA2,3,4,5, Weinstock MA2,3,6,5, Cho E2,3,4.
Editors
In: Ward WH1, Farma JM1, editors.
Source
Cutaneous Melanoma: Etiology and Therapy [Internet]. Brisbane (AU): Codon Publications; 2017 Dec. Chapter 1.
The Lancet
Oncology
Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
Michele Maio, Karl Lewis, MD, Prof Lev Demidov, MD, Mario Mandalà, MD, Igor Bondarenko, MD, Paolo A Ascierto, MD, Christopher Herbert, MD, Prof Andrzej Mackiewicz, MD, Prof Piotr Rutkowski, MD, Alexander Guminski, PhD, Grant R Goodman, MD, Brian Simmons, PharmD, Chenglin Ye, PhD, Yibing Yan, PhD, Prof Dirk Schadendorf, MD and the BRIM8 Investigators†
†Listed in the appendix
Published: 21 February 2018
DOI: https://doi.org/10.1016/S1470-2045(18)30106-2
Cancer Immunology Research
Quantitative Analysis of Immune Infiltrates in Primary Melanoma
Robyn D. Gartrell, Douglas K. Marks, Thomas D. Hart, Gen Li, Danielle R. Davari, Alan Wu, Zoe Blake, Yan Lu, Kayleigh N. Askin, Anthea Monod, Camden L. Esancy, Edward C Stack, Dan Tong Jia, Paul M. Armenta, Yichun Fu, Daisuke Izaki, Bret Taback, Raul Rabadan, Howard L. Kaufman, Charles G. Drake, Basil A. Horst and Yvonne M. Saenger
DOI: 10.1158/2326-6066.CIR-17-0360
International Journal of Cancer
Polyunsaturated fatty acids and risk of melanoma: A Mendelian randomisation analysis
Upekha E. Liyanage, Matthew H. Law, Jue Sheng Ong, Anne E. Cust, Graham J. Mann, Sarah V. Ward, Melanoma Meta-analysis Consortium, Puya Gharahkhani, Mark M. Iles, Stuart MacGregor
Accepted manuscript online: 22 February 2018
DOI: 10.1002/ijc.31334
JAMA Dermatology
Dermoscopy and Overdiagnosis of Melanoma In Situ
Kaitlin L. Nufer, BBiomedSci1; Anthony P. Raphael, PhD1; H. Peter Soyer, MD, FACD, FAHMS1
JAMA Dermatol. Published online February 21, 2018. doi:10.1001/jamadermatol.2017.6448
JAMA Dermatology
Accuracy of Dermoscopic Criteria for the Diagnosis of Melanoma In Situ
Aimilios Lallas, PhD1; Caterina Longo, PhD2; Marco Manfredini, MD3; et alElisa Benati, MD2; Graziella Babino, MD4; Chiara Chinazzo, MD4; Zoe Apalla, PhD1; Chryssoula Papageorgiou, MD1; Elvira Moscarella, MD4; Athanassios Kyrgidis, PhD2; Giuseppe Argenziano, PhD4
JAMA Dermatol. Published online February 21, 2018. doi:10.1001/jamadermatol.2017.6447
International Journal of Cancer
Polyunsaturated fatty acids and risk of melanoma: A Mendelian randomisation analysis
Authors Upekha E. Liyanage1 Matthew H. Law , 1 , Jue Sheng Ong1 , Anne E. Cust2,7 , Graham J. Mann3,7, Sarah V. Ward4,6 , Melanoma Meta-analysis Consortium*, Puya Gharahkhani1 , Mark M. Iles5 , Stuart MacGregor1
‘Accepted Article’, doi:10.1002/ijc.31334
Cancer Prevention Research
Marshaling the Translational Potential of MC1R for Precision Risk Assessment of Melanoma
Peter A. Kanetsky and Jennifer L. Hay
DOI: 10.1158/1940-6207.CAPR-17-0255
International Journal of Oncology
Cutaneous melanoma: From pathogenesis to therapy (Review)
Giulia C. Leonardi, Luca Falzone, Rossella Salemi, Antonino Zanghì, Demetrios A. Spandidos, James A. Mccubrey, Saverio Candido, Massimo Libra
Published online on: February 27, 2018 https://doi.org/10.3892/ijo.2018.4287
Pages:1071-1080
Cureus
Abscopal Effect in a Stage IV Melanoma Patient who Progressed on Pembrolizumab
James M. Tsui, Catalin Mihalcioiu, Fabio L. Cury
Published: February 27, 2018
DOI: 10.7759/cureus.2238
Cite this article as: Tsui J M, Mihalcioiu C, Cury F L (February 27, 2018) Abscopal Effect in a Stage IV Melanoma Patient who Progressed on Pembrolizumab. Cureus 10(2): e2238. doi:10.7759/cureus.2238
International Journal of Cancer
Letter to the Editor
Immigration is the most likely reason for the generational change in melanoma incidence in Queensland, Australia
Dr. D Czarnecki MD MBBS
Accepted manuscript online: 28 February 2018
DOI: 10.1002/ijc.31348